In this study, we provide the first Fourier-transform infrared absorption spectroscopy (FTIR) and Raman spectroscopy (RS) analysis of a vibrational fingerprint of erlotinib, a drug which is applied in non-small cell lung cancer therapy, in solid state and solution in different pH conditions. Additionally, the performed DFT theoretical calculations in vacuum and PCM models support the interpretation of vibrational spectra and give insight into an optimized spatial configuration of the investigated drug. e present considerations show vibrational structure of erlotinib and details of its molecular geometry. Furthermore, we discuss the pH condition where the protonated -NH + and C�N + forms occur and indicate the spectral changes characteristic for the erlotinib protonation. It is of great of importance to better understand biological activity of the drug and to develop new tyrosine kinase inhibitors.
Introduction
In the last few decades, scientific research focused on understanding tumor formation [1] [2] [3] [4] . Studies have shown that an accumulation of genetic and epigenetic mutations is one of the most serious factors promoting cancer disease [1, 2] . erefore, there is a great interest in creating extremely sensitive and specific drugs that could be used in cancer therapy. Erlotinib, known also as TARCEVA (see Figure 1 for molecular structure), is one of the drugs with particular activity against epidermal growth factor receptor (EGFR) activation [5] . Overexpression of EGFR is observed in 50% of non-small cell lung cancers (NSCLCs).
is tyrosine kinase inhibitor competes with adenosine triphosphate (ATP) for the binding side of EGFR, prevents the tyrosine phosphorylation, and thus blocks signaling pathway in the target cell. Erlotinib is applied in NSCLC therapy for patients with recognized EGFR-activating mutations [6] [7] [8] . It shows response rates of 10% to 27% in a broad NSCLC patient population after failure of chemotherapy [5] .
Previously, we have shown surface-enhanced Raman spectroscopy (SERS) investigation of erlotinib immobilized onto potential silver colloidal nanocarriers [9] . ese studies present vibrational spectroscopy characterization by means of Raman spectroscopy (RS) and Fourier-transform infrared absorption spectroscopy (FTIR) of the molecular structure of erlotinib in the solid state and solution in different pH conditions. ese two complementary methods are commonly used for qualitative and quantitative analysis of different types of samples in various conditions and physical states [10] [11] [12] [13] [14] [15] . RS and FTIR are governed by different quantum mechanical selection rules [16] . Mainly, vibrations that change polarizability of a molecule are active in RS spectra, while these which change molecular dipole moment are observed in FTIR spectra. erefore, only the use of both spectroscopic methods provides comprehensive analysis of the investigated molecular structure. Additionally, by means of the density functional theory (DFT) calculations with the B3LYP hybrid theory level, the optimized geometry, wavenumber, and intensity of the vibrational bands of the investigated drug are provided. Such calculation method provides very good agreement between the calculated spectra and the corresponding experimental spectra of many molecules [10, [17] [18] [19] [20] . Since there are a lot of publications regarding biological activity of erlotinib [21] and its successful application in NSCLC therapy [22, 23] , there are no reports describing the 3D structure of this drug in detail what determines its application. Many research data confirm that the compounds indicating similar chemical structure show different biological features [24, 25] . e spatial orientation of particular bonds determines therapeutic effect of the molecule. Deep knowledge and understanding of the molecular and geometric structure together with the recognized biological activity is important for developing new drug alternatives with more specific interaction or by improving the existing medical agents [26, 27] .
us, the present study is crucial for better understanding the biological activity of erlotinib and for development of new tyrosine kinase inhibitors.
Materials and Methods

RS Measurements.
e RS measurements for erlotinib were performed using the inVia Renishaw spectrometer combined with a CCD detector and confocal microscope Leica with the 20x magnification. e 532.8 nm laser wavelength with a 0.1% of the laser power was used as an excitation source. 3 scans were recorded in the range 2250-400 cm − 1 , each with 30 s of the integration time and at 1 cm − 1 spectral resolution.
FTIR Measurements.
e FTIR experiments were performed using the vacuum VERTEX 70v FTIR Spectrometer for powder sample in the ATR mode with diamond crystal. e system is equipped with a KBr beamsplitter and a wide range DLaTGS detector. 128 scans were enough to acquire a good signal-to-noise ratio. e signal was collected in the range 2250-400 cm − 1 at 1 cm − 1 spectral resolution. Advanced ATR correction was applied for the spectrum before data analysis.
2.3.
eoretical Calculations. In order to optimize the ground-state geometry of the investigated drug and to obtain its theoretical vibrational spectra, the Gaussian 03 suite [28] with the density functional theory (DFT) method at the B3LYP theory level in vacuum and PCM model was employed. Such hybrid functional with 6-311G(d, p) basis set was successfully applied for calculations of similar molecules [18] [19] [20] 29] . During the optimization, no imaginary wavenumbers were observed.
is implies that the optimized structures indicate energy minima on the potential energy surface for nuclear motion. e theoretical Raman intensities were calculated using Raint software, which applied the following relationship [30] :
where I i is given in arbitrary units, C is a constant and equal to 10 − 12 , ] 0 is the wavenumber of laser excitation (cm − 1 ) (18768.8 cm − 1 for 532.8 nm laser), ] i is the DFT calculated frequency of the normal mode, S i is the DFT calculated Raman scattering activity of the normal mode Q i , T is the temperature (K), h is the Planck constant, and k is the Boltzmann constant. e calculated RS and IR spectra were reproduced by the GaussSum 0.8 free software package [31] . For a better fit to the experimental vibrational bands, the theoretical wavenumbers were scaled using scaling factor of 0.991. e spectra were plotted with 11 cm − 1 FWHM (full width at half maximum) and a 50%/50% Gaussian/Lorentzian band shape.
After comparison between the experimental and calculated spectral bands, some shortcomings can be observed. Such differentiation may result from conditions occurring in the experimental measurements and performed calculations. e RS and IR spectra were recorded for the sample in a solid state, while the DFT calculations were performed in vacuum. However, the obtained correlation is appropriate. On the other hand, the theoretical RS spectrum calculated in a PCM model corresponds very well with that measured in a solution. 
Results and Discussion
3.1. Molecular Geometry. In order to identify the stable structure of erlotinib, twenty conformers were taken into consideration. Based on the differences between the calculated total energies of the examined conformers from DFT, the structure with the lowest energy was chosen for further analysis. Additionally, the theoretical RS and IR spectra of the selected conformer provide the best match to the experimental results. e bond lengths and angles of the optimized erlotinib structure obtained by means of the DFT/ B3LYP method with 6-311G(d, p) basis set are given in Table 1 , and the numbering of atoms is provided in Figure 1 . e calculated value of the C≡C (C 1 -C 2 ) bond which is 1.204Å is comparable with the typical C≡C bond of the phenylacetylene (1.216Å) [32, 33] . Similar observation occurs for the C 2 -C 3 and C 3 -C 4 bonds (see Figure 1 ), where for erlotinib, these distances are 1.430Å and 1.403Å, respectively. e corresponding bond lengths of the phenylacetylene molecule are equal to 1.448Å and 1.395Å, respectively [32] . In the case of the quinazoline moiety, which consisted of two fused aromatic rings, namely, benzene and pyrimidine rings, the C-N bonds indicate definitely shorter length in comparison with the corresponding bonds observed in the pyrimidine [34] . e C 16 -N 17 , N 17 -C 18 , C 18 -N 19 , and N 19 -C 10 bonds are equal to 1.367Å, 1.310Å, 1.351Å, and 1.323Å, respectively, while in the pyrimidine analogues [34] , these bonds are 1.382Å, 1.379Å, 1.378Å, and 1.374Å, respectively. Also, the calculated angle bonds C 16 -N 17 -C 18 and C 18 -N 19 -C 10 (115.6°a nd 117.4°, respectively) differ from the corresponding angles of the pyrimidine [30] , which are equivalent to 125.7°a nd 126.0°, respectively. On the other hand, the C-O bonds in the ethoxy moieties of the calculated erlotinib structure are almost the same length as the corresponding bonds in the ethoxy isomers [35, 36] . e C 13 -O 20 , C 14 -O 25 bonds and the O 20 -C 21 , O 25 -C 26 bonds are equal to 1.364Å, 1.356Å and 1.441Å, 1.428Å, respectively, while for the ethoxy benzaldehyde derivatives [32] , these bonds are 1.359Å and 1.433Å, respectively. However, there are some differences for the C-O-C and O-C-C bond angles of erlotinib in comparison with those from the mentioned aromatic isomer [35] . e C 13 -O 20 -C 21 , C 14 In the case of the corresponding bonds [35, 36] , these angles are equal to 116.6°and 107.7°, respectively. Figure 2 presents experimental and theoretical RS and FTIR spectra for the erlotinib drug in the spectral range of 2250-400 cm − 1 . e theoretical Table 1 : e selected calculated bond lengths and angles of erlotinib.
RS, FTIR, and DFT Studies.
Bond
Bond length (Å) Bonds Angle (°) Bonds Dihedral angle (°) C 1 -C 2 1.204 C 2 -C 3 -C 8 119.5 C 6 -C 7 -N 9 -C 10 − 179.3 C 2 -C 3 1.430 C 8 -C 7 -N 9 124.5 N 9 -C 10 -C 11 -C 12 1.071 C 3 -C 4 1.403 N 9 -C 10 -N 19 120.0 C 11 -C 12 -C 13 -O 20 174.9 C 4 -C 5 1.390 N 9 -C 10 -C 11 118.8 C 16 -C 15 -C 14 -O 25 − 179.1 C 5 -C 6 1.388 C 10 -C 11 12 1.414 C 15 -C 14 -O 25 125.0 C 12 -C 13 1.374 C 14 -O 25 -C 26 118.9 C 13 -C 14 1.433 O 25 -C 26 -C 27 108.4 C 14 -C 15 1.378 C 26 -C 27 -O 28 109.4 C 15 -C 16 1.414 C 27 -O 28 -C 29 112.8 C 16 -N 17 1.367 N 17 -C 18 1.310 C 18 -N 19 1.351 N 19 -C 10 1.323 C 11 -C 16 1.418 C 13 -O 20 1.364 O 20 -C 21 1.441 C 21 -C 22 1.519 C 22 -O 23 1.418 O 23 -C 24 1.412 C 14 -O 25 1.356 O 25 -C 26 1.428 C 26 -C 27 1.511 C 27 -O 28 1.412 O 28 -C 29 1.414
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wavenumbers, calculated at the DFT/B3LYP/6-311G(d, p) level in vacuum, demonstrate good correlation with the experimental bands. Moreover, the vibrational spectra for the aniline [37] and pyrimidine [38, 39] and RS spectra for phenylacetylene [40] and erlotinib [41, 42] were taken into consideration. All wavenumbers together with the appropriate assignments are listed in Table 2 .
Aromatic Vibrations.
As expected, the most intense RS bands are due to the vibrations of the phenylacetylene and quinazoline moieties (see Figure 2(a) ). e bands assigned to the phenylacetylene ring modes, namely, ν(C≡C), ν(CC) Phe , ρ b (CH) Phe 
Journal of Spectroscopy 1170-1166 cm − 1 , 1004-1001 cm − 1 , 700-702 cm − 1 , 651-641 cm − 1 , 624-619 cm − 1 , and 598 cm − 1 , respectively (see Table 2 ). Some of these bands appear also in the corresponding FTIR spectrum (see Figure 2 
Aliphatic Vibrations.
e presence of the methoxy and ethoxy groups is manifested by the several characteristic RS and FTIR spectral features (see Figure 2 ). ese bands appear in the spectral ranges 1514-1513 cm − 1 , 1230-1222 cm − 1 , 1128-1126 cm − 1 , 1083 cm − 1 , 1075-1072 cm − 1 , 1052-1049 cm − 1 , 877-871 cm − 1 , and 463-455 cm − 1 and correspond to the ρ s (CH 2 ) OCH2 /ρ s (CH 2 ) CH3 /ρ s (CH 2 ) CH2O , ρ w/t (CH 2 ) CH3 / ν(CO) CH2O , δ(CH), ν(CC) CH2-CH2 /ρ w (CH 2 ) CH3 , ν(OC) OCH2 / ρ r (CH 2 ), ν(CC) CH2-CH2 /ν(OC) OCH3 , ρ r (OC 2 H 4 ), and δ(CCO)/ δ(COC) vibrations, respectively. In the case of the amino moiety, the strong and medium intensity bands due to the ρ b (NH) and ν(CN) modes occur in the spectral ranges 1534-1532 cm − 1 , 1447-1441 cm − 1 , and 1278-1275 cm − 1 , respectively. Additionally, this functional group indicates contribution to the spectral features at 1413-1403 cm − 1 and 1372-1364 cm − 1 assigned to the ρ b (NH) mode.
pH-dependent RS Studies.
Due to the possible protonation occurring for the amino and quinazoline moieties of erlotinib, the RS experiments in various pH conditions were performed. Figure 3 presents the RS spectra of the investigated drug at pH between 3 and 11 in the spectral range of 2250-400 cm − 1 . Additionally, the calculations at the DFT/B3LYP/6-311G(d, p) level in PCM model were performed. e theoretical RS spectrum correlates very well with the corresponding RS spectrum measured for the investigated drug at pH � 7 (see Figure 3) . Table 3 lists the wavenumbers and the appropriate band assignments. e obtained vibrational data indicate almost the same spectral pattern; however, some relative intensity changes become Tables 2 and 3 ). Nevertheless, together with the pH increasing from 7 to 11, the crucial weakening of the band intensities especially related to the ρb(NH) vibrations is observed (see Figure 3 ). According to the literature, the erlotinib dissociation constant is equal to 5.4 [43] ; thus, the spectral patterns discussed above should be the result of the -NH + presence in the acidic medium and its absence in the neutral and alkaline environments. In the case of quinazoline, the observed spectral variations suggest that the protonation for this moiety may also occur. e strong and medium intensity bands at ∼1408 cm − 1 [ν(C�N) Q ] and ∼1308 cm − 1 [ν(CC) Q ]/ν(CN) Q ] and ∼1241 cm − 1 [ν(CC) Q ]/ ν(CN) Q ] in the RS spectra for erlotinib at pH equal to 3 and 5 indicate significant weakening and shift to ∼1394 cm − 1 and ∼1311 cm − 1 and ∼1246 cm − 1 , respectively, when the pH rises above 7 (see Figure 3 ). Such phenomenon may support the statement that in the acidic medium, the protonated C�N + form occurs. is is also confirmed by the noticed blue shift for the band assigned to ν(CC) Phe-Q from ∼1590 cm − 1 (pH � 3) to ∼1596 cm − 1 (pH � 11) upon pH values increasing (see Figure 3 ). is spectral feature has been already considered as a pH-sensitive band [44] . Furthermore, in the RS spectrum for erlotinib at pH � 5 appear bands associated with the ethoxy group vibrations. e mentioned bands are visible at ∼1513 cm − 1 and ∼1345 cm − 1 , and they are assigned to the ρ s (CH 2 ) and ρ w (CH 2 ), respectively. Intensity of these bands becomes stronger upon pH increasing. Moreover, in the neutral and alkaline environments, bands at ∼1230 cm − 1 and ∼702 cm − 1 occur due to the ρ w/t (CH 2 )CH 3 /ν(CO) CH2O and δ(C Q OC) modes.
Conclusions
In this study, we performed the first characterization of vibrational structure of erlotinib, a drug approved in NSCLC therapy, based on RS and FTIR spectroscopies in solid state and solution in different pH conditions. Additionally, the optimized molecular structure of erlotinib was elucidated in detail based on the experimental data, which were supported by DFT/6-311G(d, p) calculations. Simultaneously, the performed RS measurements for the investigated drug in different pH conditions show that in the acidic environment, the protonated -NH + and C�N + forms occur.
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